pindolol has been researched along with Autoimmune Diabetes in 6 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Orthostatic hypotension is one of the most troublesome symptoms in diabetic autonomic neuropathy." | 2.66 | No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study. ( Dejgård, A; Hilsted, J, 1988) |
| "We divided the patients with IDDM into two groups based on their level of blood glycosylated hemoglobin (HbA1) when samples were taken." | 1.27 | Adaptive regulation of beta-adrenergic receptors in children with insulin dependent diabetes mellitus. ( Kuroume, T; Nagashima, K; Noji, T; Suzuki, S; Tashiro, M; Yagi, H, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwab, KO | 1 |
| Bartels, H | 1 |
| Martin, C | 1 |
| Leichtenschlag, EM | 1 |
| Yu, O | 1 |
| Ouyang, A | 1 |
| Dejgaard, A | 1 |
| Liggett, SB | 1 |
| Christensen, NJ | 1 |
| Cryer, PE | 1 |
| Hilsted, J | 2 |
| Andersen, EB | 1 |
| Lindskov, HO | 1 |
| Marving, J | 1 |
| Boesen, F | 1 |
| Beck-Nielsen, H | 1 |
| Hesse, B | 1 |
| Noji, T | 1 |
| Tashiro, M | 1 |
| Yagi, H | 1 |
| Nagashima, K | 1 |
| Suzuki, S | 1 |
| Kuroume, T | 1 |
| Dejgård, A | 1 |
1 trial available for pindolol and Autoimmune Diabetes
| Article | Year |
|---|---|
No effect of Pindolol on postural hypotension in type 1 (insulin-dependent) diabetic patients with autonomic neuropathy. A randomised double-blind controlled study.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Neuropathies; D | 1988 |
5 other studies available for pindolol and Autoimmune Diabetes
| Article | Year |
|---|---|
Decreased beta 2-adrenoceptor density and decreased isoproterenol induced c-AMP increase in juvenile type I diabetes mellitus: an additional cause of severe hypoglycaemia in childhood diabetes?
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclic AMP; Diabetes Mellitus, Type 1; Granulocytes; Hum | 1993 |
Distribution of beta-adrenoceptor subtypes in gastrointestinal tract of nondiabetic and diabetic BB rats. A longitudinal study.
Topics: Adrenergic beta-Antagonists; Aging; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Typ | 1997 |
Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity.
Topics: Adult; Cell Membrane; Cyclic AMP; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Epinephrine; Hum | 1991 |
Decrease in beta-receptor density explaining the development of pindolol- and prenalterol-tolerance in orthostatic hypotension.
Topics: Adrenergic beta-Agonists; Diabetes Mellitus, Type 1; Drug Tolerance; Female; Humans; Hypotension, Or | 1985 |
Adaptive regulation of beta-adrenergic receptors in children with insulin dependent diabetes mellitus.
Topics: Adolescent; Adult; Cell Membrane; Child; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Hum | 1986 |